July 1986

Long-term Suppression of Recurrent Herpes Labialis by Low-Dose Oral Acyclovir in an Immunocompromised Patient

Author Affiliations

From the Infectious Diseases Unit (Drs Dan, Siegman-Igra, and Michaeli) and Department of Microbiology (Mrs Weinberg), Ichilov Hospital, Tel Aviv (Israel) Medical Center; and Tel Aviv University Sackler School of Medicine (Drs Dan, Siegman-Igra, and Michaeli and Mrs Weinberg).

Arch Intern Med. 1986;146(7):1438-1440. doi:10.1001/archinte.1986.00360190230035

• A patient with chronic lymphocytic leukemia and severe and frequently recurring herpes labialis received oral acyclovir for more than 18 months, during most of this period at a low dosage (400 mg/d). This regimen was fully successful in preventing recurrences, with no adverse effects.

(Arch Intern Med 1986;146:1438-1440)